J07AM51 - Tetanus Toxoid, Combinations with Diphtheria Toxoid |
Probably not porphyrinogenic |
PNP |
Mono.Rationale
Based on the pharmacokinetics of the tetanus toxoid, combinations with diphtheria toxoid vaccine, there are no conceivable porphyrinogenic effects.
Mono.ChemicalDescription
Purified tetanus toxoid and diphtheria toxoid.
Mono.TherapeuticCharacteristics
The tetanus- and diphtheria –toxoid combination vaccine is indicated for booster vaccination against diphtheria and tetanus of individuals from the age of five years onwards. It is administered as a single intramuscular injection.
Mono.MetabolismAndPharmacokinetics
The tetanus toxoid, combinations vaccine is not metabolized by the cytochrome P450 system.
Mono.SimilarDrugs
Mono.References
| # | Citation details | PubMed ID |
|---|---|---|
| Government bodies | ||
| 1. | Norwegian Institute of Public Health. Vaksinasjonsveilederen. www.fhi.no (updated 13.10.2015).
|
|
| Summary of Product Characteristics | ||
| 2. | Norwegian medicines agency. Summary of Product Characteristics (SPC). diTeBooster.
|
|
Mono.Tradenames